In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 74 for your search:
Drug:  therapeutic autologous lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC0681, P30CA015083, 07-000789, MAYO-MC0681, NCT00566228

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: IcmLCBT_301, NCT00807027

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069072, P30CA022453, 2006-130, RWMC-0635146, WSU-010307M1F, WSU-0312004412, WSU-2006-130, NCT00027807

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: STLMC-IMM-0104, L-01-108, STLMC-L-01108, NCI-V01-1686, NCT00030342

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PPMC-EACRI-IRB-02-119, DOD Grant #DAMD17-03-1-0097, NCT00122005

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: rM28-001, NCT00204594

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 12 to 75
Sponsor: Other
Protocol IDs: CIK#1/2006, NCT00394381

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: MSGCC-0610-GCC, 0610 GCC, UPCC-0610-GCC, NCT00499577

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: J0770 JHU, P30CA006973, JHOC-J0770, J0770, NCT00566098

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 20 to 80
Sponsor: Other
Protocol IDs: TRIC-CTR-GU-05-01, CTR GU 05-01, NCT00588913

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 19 months to 35 years
Sponsor: NCI
Protocol IDs: 070206, 07-C-0206, NCT00923351

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: CDR0000256870, MSGCC-0065, UPCC-6401, NCI-V02-1709, NCT00046852

13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2179.00, NCI-2010-01281, FHCRC-2179.00, 6558, NCT00553306

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: P080601, NCT00986518

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TVI-AST-002, NCT01081223

16.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 09174, NCI-2011-00344, P50 CA107399, NCT01318317

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000064192, NCI-95-C-0105A, NCI-T94-0096N, T94-0096, NCT00019084

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: 970050, 97-C-0050, NCI-97-C-0050K, NCI-T96-0037, T96-0037, NCT00019279, NCT00001564

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067241, P30CA022453, WSU-C-1403-ME, NCI-G99-1565, NCT00004022

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067243, P30CA022453, WSU-C-1403-BT, NCI-G99-1567, NCT00004024

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: 990158, 99-C-0158, NCI-99-C-0158, NCI-T99-0078, T99-0078, NCT00019942, NCT00001832

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000068559, P30CA022453, WSU-D-1654, WSU-07-92-98-P04-FB, NCI-G01-1937, NCT00014573

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068707, P30CA22453, WSU-2007-033, RWMC-0634246, NCT00020722

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-11447A, NCI-1330, NCT00064168, 1330

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000354491, NCI-04-C-0104, NCI-6233, 6233, NCT00079144
1    
New Search